{"status":"OK","data":{"advertisement":{"id":296833,"title":"Zakup i dostawa odczynnik\u00f3w (preparatu leczniczego) / Purchase and delivery of reagents (medicinal product)","partial_offer_allowed":false,"publication_date":"2025-04-17","submission_deadline":"2025-05-19 23:59:59","planned_sign_date":null,"supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-05-20 00:00:05","contact_persons":[{"id":206,"forename":"Gra\u017cyna","surname":"G\u00f3ra","phone_number":"723170234","email":"grazyna.gora@rezonbio.com","created_by":null,"created_at":"2026-10-26 14:06:10","modified_at":"2026-10-26 14:06:10","modified_by":null}],"orders":[{"id":481646,"estimated_value":null,"order_items":[{"id":543181,"description":"1. Preparat leczniczy ENTYVIO 300 mg - serie EU (Medicinal product ENTYVIO 300mg  - EU  batch) (*)\n2. Preparat leczniczy ENTYVIO 300 mg - serie EU (Medicinal product ENTYVIO 300mg  - EU  batch) (*)\n(*) lub r\u00f3wnowa\u017cny\n\nPe\u0142na tre\u015b\u0107 zapytanie ofertowego znajduje si\u0119 w Za\u0142\u0105czniku nr 1. / The full text of the Content of the\nrequest for quotation can be found in Appendix No. 1A \n\nW dniu 17.04.2025 Zamawiaj\u0105cy wprowadzi\u0142 zmian\u0119 w tre\u015bci Za\u0142\u0105cznika nr 1A. Obowi\u0105zuj\u0105cy jest Za\u0142\u0105cznik nr 1B, traci moc Za\u0142\u0105cznik nr 1A. / The Ordering Party introduced a revision to the content of Appendix No. 1A on April 17,2025. Appendix No. 1B is now the prevailing document, rendering Appendix No. 1A obsolete. \nZmiana opisana w Za\u0142\u0105czniku - Szczeg\u00f3\u0142owy opis zmiany ZO / The change described in the Appendix - Detailed description of the change of RFP","warranty_period":null,"cpv_items":[{"id":3148,"code":"33696500-0","name":"Odczynniki laboratoryjne"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"pomorskie","poviat":"Gda\u0144sk","commune":"Gda\u0144sk","locality":"Gda\u0144sk","created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null,"id":613466,"type":{"id":1,"name":"adres"},"group_uuid":"8fe9d80e-5d22-417f-8e74-da8a7099f5a7"}],"participation_conditions":[{"id":1516977,"description":"Szczeg\u00f3\u0142owy opis warunk\u00f3w znajduje si\u0119 w Za\u0142\u0105czniku nr 1 / A detailed description\ncriteria in English can be found in Appendix 1A","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null,"group_uuid":"5e9a88cd-27ba-4995-b8f1-cb2d916f6bd3"}],"category":{"id":3,"name":"Dostawa"},"subcategory":{"id":15,"name":"Dostawy inne"},"created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null,"group_uuid":"1f370ed1-f2f9-4806-a183-57fe320c97b6"}],"evaluation_criteria":[{"id":849305,"price_criterion":true,"description":"Cena - 80%\nSzczeg\u00f3\u0142owy opis kryterium oceny ofert znajduje si\u0119 w Za\u0142\u0105czniku nr 1 /A detailed description of the offer evaluation criteria in English can be found in Appendix 1A","created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null,"group_uuid":"83d809c8-77d5-4881-9c3f-b8b8a3c84279"},{"id":849306,"price_criterion":false,"description":"Czas dostawy - 20%\nSzczeg\u00f3\u0142owy opis kryterium oceny ofert znajduje si\u0119 w Za\u0142\u0105czniku nr 1 /A detailed description of the offer evaluation criteria in English can be found in Appendix 1A","created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null,"group_uuid":"95946656-bf6c-4aee-97e0-01ac627857f7"}],"is_variant":false,"title":"Zakup i dostawa odczynnik\u00f3w (preparatu leczniczego) ","order_node":{"id":364647},"created_by":null,"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":null}],"created_by":{"id":377,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Polpharma Biologics S.A.","identification_number_type":"nip","identification_number":"9571112470","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"Gda\u0144sk","commune":"Gda\u0144sk","locality":"Gda\u0144sk","created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":{"id":377,"contact_persons":[]},"id":823754,"street":"Trzy Lipy ","number_description":"3","postcode":"80-172"},"created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-17 17:20:36","modified_at":"2025-04-17 17:20:36","modified_by":{"id":377,"contact_persons":[]},"id":297629},"advertisement":{"id":225197,"number":"2025-377-225197","publication_date":"2025-04-17","created_by":{"id":377,"contact_persons":[]},"created_at":"2025-04-17 11:46:24","modified_at":"2025-05-20 00:00:05","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[296683,296831,296832,296833],"enrollment":null,"projects":[{"id":46637,"name":"Opracowanie innowacyjnej postaci leku zawieraj\u0105cego przeciwcia\u0142o monoklonalne do stosowania w leczeniu nieswoistych stan\u00f3w zapalnych jelit \u2013 II faza","number":"1014/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-1014/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":377,"contact_persons":[]},"created_at":"2024-06-06 09:35:19","modified_at":"2024-06-06 09:35:19","modified_by":{"id":377,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":296683,"publication_date":"2025-04-17"},"id":1783324,"name":"Za\u0142\u0105cznik 1 Tre\u015b\u0107 zapytania ofertowego","file":{"id":1985829,"name":"Za\u0142\u0105cznik Nr 1 Tre\u015b\u0107 zapytania ofertowego.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1985829"},"group_uuid":"edf2e2f3-fe08-4963-9e66-bbcc3ffbd9a2"},{"origin":{"id":296683,"publication_date":"2025-04-17"},"id":1783325,"name":"Za\u0142\u0105cznik nr 2 O\u015bwiadczenie o braku powi\u0105za\u0144","file":{"id":1985833,"name":"Za\u0142\u0105cznik Nr 2 - O\u015bwiadczenie o braku powi\u0105za\u0144.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1985833"},"group_uuid":"cce74013-9db4-441d-995b-6e67fa58eab1"},{"origin":{"id":296683,"publication_date":"2025-04-17"},"id":1783326,"name":"Appendix No 1A Content of the request for quotation","file":{"id":1985838,"name":"Appendix No 1A - Content of the request for quotation.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1985838"},"group_uuid":"d7cf6d2a-eb87-4588-8f94-72d0a26d3c21"},{"origin":{"id":296683,"publication_date":"2025-04-17"},"id":1783327,"name":"Appendix No 2A  Statement of Non-Affiliation with confirmation","file":{"id":1985840,"name":"Appendix Nr 2A -  Statement of Non-Affiliation with confirmation.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1985840"},"group_uuid":"557e5b9e-3085-4a4c-bd74-a75fdd0bda13"},{"origin":{"id":296831,"publication_date":"2025-04-17"},"id":1784927,"name":"Appendix No 1B Content of the request for quotation","file":{"id":1987593,"name":"Appendix No 1B - Content of the request for quotation.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1987593"},"group_uuid":"7a4e9003-9b1b-4188-8c13-3565222fb490"},{"origin":{"id":296832,"publication_date":"2025-04-17"},"id":1784934,"name":"Szczeg\u00f3\u0142owy opis zmiany ZO_Detailed description of the change of RFP","file":{"id":1987597,"name":"Szczeg\u00f3\u0142owy opis zmiany ZO_Detailed description of the change of RFP.pdf","created_at":"2025-04-17 17:20:36","created_by":{"forename":"Gra\u017cyna","surname":"G\u00f3ra"},"uri":"/api/files/1987597"},"group_uuid":"01fda2f5-803f-4adf-b749-81b58afde340"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}